nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
您当前所在位置: 首页> 文献列表> 中医药调控mTOR通路干预溃疡性结肠炎及其癌变研究进展
2025, 06, v.44 711-720
中医药调控mTOR通路干预溃疡性结肠炎及其癌变研究进展
基金项目(Foundation): 国家自然科学基金项目(编号:82205057)
邮箱(Email): riri17686146939@163.com;
DOI: 10.16295/j.cnki.0257-358x.2025.06.019
发布时间: 2025-06-05
出版时间: 2025-06-05
移动端阅读
摘要:

溃疡性结肠炎(UC)病理损伤的重要因素之一是免疫应答异常引起的炎症反应,炎症因子的过度表达是促进炎癌转化的重要因素,引起组织病理损伤,诱导上皮内瘤变,形成肿瘤。雷帕霉素靶蛋白(mTOR)作为调控细胞生长、自噬和免疫应答的核心通路,在UC及其癌变中发挥着双重作用:一方面通过抑制自噬,加剧肠道炎症;另一方面驱动癌细胞增殖。研究发现中医药可通过腺苷酸活化蛋白激酶(AMPK)-mTOR、蛋白激酶B(Akt)-mTOR等通路调控自噬、抑制炎症因子,且不良反应较少,为UC及炎癌转化提供了潜在治疗策略。具体而言,中药有效成分如黄连素、黄柏碱等,以及中药复方白头翁汤等,可通过激活AMPK通路负调控自噬,抑制mTOR磷酸化,促进细胞自噬,改善UC炎症反应;干姜提取物、人参根提取物等能抑制Akt-mTOR通路,减少炎症因子分泌,干预细胞凋亡。参考文献59篇。

Abstract:

One of the important factors of pathological damage in ulcerative colitis(UC) is the inflammatory response caused by abnormal immune response. The overexpression of inflammatory cytokine is an important factor promoting the transformation of inflammation to cancer,causing histopathological damage,inducing intraepithelial neoplasia,and forming tumors. The mammalian target of rapamycin(mTOR),as the core pathway regulating cell growth,autophagy and immune response,plays a dual role in UC and its carcinogenesis:on the one hand,it aggravates intestinal inflammation by inhibiting autophagy;On the other hand,it drives the proliferation of cancer cells. Studies have found that traditional Chinese medicine can regulate autophagy and inhibit inflammatory cytokine through pathways such as amp-activated protein kinase(AMPK)-m TOR and Akt-mTOR,with relatively low adverse reactions,providing potential therapeutic strategies for treating UC and inflammation-cancer transformation. Specifically,the active ingredients of traditional Chinese medicine such as berberine and phellodenine,as well as the traditional Chinese medicine compound Baitouweng Decoction(白头翁汤),can negatively regulate autophagy by activating the AMPK pathway,inhibit the phosphorylation of m TOR,promote autophagy in cells,and improve the inflammatory response of UC. Extracts of dried ginger,ginseng root,etc. can inhibit the Akt-m TOR pathway,reduce inflammatory cytokine secretion and intervene in cell apoptosis. There are 59 references.

参考文献

[1]李荣荣,杨维肖,李毅.扶阳活血解毒方对溃疡性结肠炎模型大鼠血清IL-17、IL-10水平的影响[J].山东中医杂志,2020,39(11):1228-1232.

[2]郑薇薇,潘林康,刘兴山.溃结方联合隔药灸治疗大肠湿热型溃疡性结肠炎疗效观察[J].山东中医药大学学报,2020,44(4):410-413.

[3]崔莉,宁青,张润桐,等.黄芩多糖提取条件优化方法及其对溃疡性结肠炎小鼠的疗效研究[J].山东中医杂志,2020,39(9):993-1000.

[4] SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249.

[5]王念德,王树庆,臧奉娇,等.补肾活髓颗粒对慢性再生障碍性贫血患者mTOR信号通路的影响[J].山东中医杂志,2017,36(7):558-561.

[6] LUO C,YE W R,SHI W,et al. Perfect match:mTOR inhibitors and tuberous sclerosis complex[J]. Orphanet J Rare Dis,2022,17(1):106.

[7] SANCHEZ-GARRIDO J,SHENOY A R. Regulation and repurposing of nutrient sensing and autophagy in innate immunity[J]. Autophagy,2021,17(7):1571-1591.

[8] GIGUèRE V. Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth[J]. FEBS J,2018,285(9):1572-1588.

[9]刘珊山,卢利霞,李斌,等.自噬和肠道微生物群在溃疡性结肠炎中的研究进展[J].胃肠病学和肝病学杂志,2023,32(9):1048-1052.

[10] LARABI A,BARNICH N,NGUYEN H T T. New insights into the interplay between autophagy,gut microbiota and inflammatory responses in IBD[J]. Autophagy,2020,16(1):38-51.

[11] CHEN S L,LI C M,LI W,et al. How autophagy,a potential therapeutic target,regulates intestinal inflammation[J]. Front Immunol,2023,14:1087677.

[12] LYONS J,GHAZI P C,STARCHENKO A,et al. The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile[J]. PLoS Biol,2018,16(3):e2002417.

[13]LIN X,SUN Q,ZHOU L,et al. Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses[J]. Mucosal Immunol,2018,11(6):1663-1673.

[14] HOOPER K M,BARLOW P G,STEVENS C,et al. Inflammatory bowel disease drugs:a focus on autophagy[J]. J Crohns Colitis,2017,11(1):118-127.

[15] EL-KHIDER F,MCDONALD C. Links of autophagy dysfunction to inflammatory bowel disease onset[J].Dig Dis,2016,34(1-2):27-34.

[16] ONORATI A V,DYCZYNSKI M,OJHA R,et al. Targeting autophagy in cancer[J]. Cancer,2018,124(16):3307-3318.

[17] BOUYAHYA A,EL ALLAM A,ABOULAGHRAS S,et al. Targeting mTOR as a cancer therapy:recent advances in natural bioactive compounds and immunotherapy[J]. Cancers(Basel),2022,14(22):5520.

[18] FRANCIPANE M G,LAGASSE E. mTOR pathway in colorectal cancer:an update[J]. Oncotarget,2014,155(1):49-66.

[19] NEGANOVA I,TILGNER K,BUSKIN A,et al. CDK1plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells[J]. Cell Death Dis,2014,5(11):e1508.

[20] SU S,WANG X,XI X N,et al. Phellodendrine promotes autophagy by regulating the AMPK/mTOR pathway and treats ulcerative colitis[J]. J Cell Mol Med,2021,25(12):5707-5720.

[21] XU X F,LI W,YU Z D,et al. Berberine ameliorates dextran sulfate sodium-induced ulcerative colitis and inhibits the secretion of gut lysozyme via promoting autophagy[J]. Metabolites,2022,12(8):676.

[22] LI H,PANG B,NIE B,et al. Dioscin promotes autophagy by regulating the AMPK-mTOR pathway in ulcerative colitis[J]. Immunopharmacol Immunotoxicol,2022,44(2):238-246.

[23] ZHANG H H,LANG W Y,LIU X,et al. Procyanidin A1 alleviates DSS-induced ulcerative colitis via regulating AMPK/mTOR/p70S6K-mediated autophagy[J]. J Physiol Biochem,2022,78(1):213-227.

[24] YANG Y X,YUAN Y,XIA B N. Cinnamtannin D1ameliorates DSS-induced colitis by preventing Th17/Treg imbalance through activation of the AMPK/mTOR pathway[J]. Allergol Immunopathol(Madr),2022,50(5):153-161.

[25] PAN S M,WANG C L,HU Z F,et al. Baitouweng decoction repairs the intestinal barrier in DSS-induced colitis mice via regulation of AMPK/mTOR-mediated autophagy[J]. J Ethnopharmacol,2024,318(Pt A):116888.

[26]武荣林,徐慧超,蒋子文,等.电针“肠病方”对急性溃疡性结肠炎大鼠结肠自噬及AMPK/mTOR信号通路的影响[J].针刺研究,2023,48(8):818-824.

[27]陈灵,高艳云,姚昶,等.干姜提取物对溃疡性结肠炎小鼠的改善作用[J].中国食品添加剂,2023,34(8):70-77.

[28]罗爽,罗霞,刘琦,等.大黄酸对DSS诱导溃疡性结肠炎小鼠的治疗作用及机制探讨[J].中国实验方剂学杂志,2017,23(11):109-113.

[29] YANG S,LI F Y,LU S Y,et al. Ginseng root extract attenuates inflammation by inhibiting the MAPK/NF-κB signaling pathway and activating autophagy and p62-Nrf2-Keap1 signaling in vitro and in vivo[J]. J Ethnopharmacol,2022,283:114739.

[30]余飞浩,吴甜甜,栾思宇,等.苦参素干预Akt/mTOR通路调节记忆性B细胞治疗溃疡性结肠炎作用机制研究[J].时珍国医国药,2023,34(3):537-541.

[31] BAI D S,ZHAO Y,ZHU Q,et al. LZ205,a newly synthesized flavonoid compound,exerts anti-inflammatory effect by inhibiting M1 macrophage polarization through regulating PI3K/Akt/mTOR signaling pathway[J]. Exp Cell Res,2018,364(1):84-94.

[32] WU J,LUO Y T,SHEN Y,et al. Integrated metabonomics and network pharmacology to reveal the action mechanism effect of Shaoyao decoction on ulcerative colitis[J]. Drug Des Devel Ther,2022,16:3739-3776.

[33]吴丽红,李冰莹,徐志强,等.左金丸治疗寒热错杂型溃疡性结肠炎的临床观察及机制研究[J].江西中医药,2023,54(1):36-41.

[34]战晶玉,袁星星,王炳予,等.连草泻痢胶囊对溃疡性结肠炎小鼠模型肠黏膜炎症因子及TLR4/PI3K/Akt/mTOR信号通路的影响[J].海南医学院学报,2021,27(24):1872-1877.

[35]肖佑,肖超,肖戈,等.复方芩柏颗粒剂通过靶向干预miR-199-3p对溃疡性结肠炎的改善作用[J].中国临床药理学杂志,2020,36(9):1100-1103.

[36]龙健,金晶,涂能能,等.四神丸对结肠炎小鼠PI3K/Akt信号的调节作用[J].时珍国医国药,2022,33(8):1829-1832.

[37] LEE S Y,TSAI W C,LIN J C,et al. AstragalosideⅡpromotes intestinal epithelial repair by enhancing Larginine uptake and activating the mTOR pathway[J].Sci Rep,2017,7(1):12302.

[38] LI M X,LI M Y,LEI J X,et al. Huangqin decoction ameliorates DSS-induced ulcerative colitis:role of gut microbiota and amino acid metabolism,mTOR pathway and intestinal epithelial barrier[J]. Phytomedicine,2022,100:154052.

[39]代继源,刘文杰,王春辉.大黄酚介导AMPK依赖性信号通路抑制结肠癌SW480细胞的增殖、侵袭和裸鼠体内肿瘤形成[J].中国免疫学杂志,2020,36(14):1688-1694.

[40]王浩,刘志毅,张斌,等.红景天苷调节AMPK/mTOR/ULK1信号通路对结肠癌SW480细胞裸鼠的肝脏损伤的影响[J].现代生物医学进展,2023,23(17):3226-3231.

[41] BU H Q,LIU D L,ZHANG G L,et al. AMPK/mTOR/ULK1 axis-mediated pathway participates in apoptosis and autophagy induction by oridonin in colon cancer DLD-1 cells[J]. Onco Targets Ther,2020,13:8533-8545.

[42] QI W C,ZHOU X T,WANG J Q,et al. Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling[J]. Carbohydr Polym,2020,237:116113.

[43] NI X,SHANG F S,WANG T F,et al. Ellagic acid induces apoptosis and autophagy in colon cancer through the AMPK/mTOR pathway[J]. Tissue Cell,2023,81:102032.

[44] HU C X,CAO Y B,LI P,et al. Oleanolic acid induces autophagy and apoptosis via the AMPK-mTOR signaling pathway in colon cancer[J]. J Oncol,2021,2021:8281718.

[45]金少雄,邱成志,林清江,等.原苏木素B抗结肠癌细胞的作用及机制[J].吉林医学,2023,44(8):2067-2071.

[46]王密,翁春燕.血根碱基于PI3K/Akt通路抑制结肠癌细胞增殖和迁移的机制研究[J].浙江中西医结合杂志,2023,33(9):803-807.

[47]赵革,张丹,杨小会,等.丁香活性组分抑制PI3K/Akt/mTOR通路诱导人结肠癌HCT116细胞凋亡的研究[J].中国中药杂志,2021,46(5):1197-1204.

[48]刘欢,梁丽英,刘显,等.白花丹醌对人结肠腺癌Caco-2细胞凋亡、自噬及PI3K/Akt/mTOR信号通路的影响[J].中国病理生理杂志,2021,37(2):255-262.

[49]朱丽娟,罗建云,宋润泽,等.当归挥发油通过抑制PI3K/Akt/mTOR信号转导通路影响人结肠癌LOVO细胞自噬研究[J].中国现代应用药学,2022,39(4):437-441.

[50]张琳,郑丽,袁年平,等.丹酚酸B对结肠癌HCT116细胞增殖的抑制作用机制研究[J].中国临床药理学杂志,2020,36(20):3268-3271.

[51] ZHANG X J,LIU Z Z,CHEN S P,et al. A new discovery:total bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway[J]. J Ethnopharmacol,2022,283:114742.

[52] ZHU H,ZHAO N,JIANG M Z. Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway[J].Biochem Cell Biol,2021,99(6):741-749.

[53]俞燕丽,傅睿.连翘提取物通过PI3K-Akt-mTOR信号通路逆转结肠癌氟尿嘧啶耐药细胞株的研究[J].新中医,2019,51(5):27-30.

[54]苏建伟,周喜汉,叶颖霞,等.苦参碱逆转人结肠癌干细胞化疗耐药作用及相关机制研究[J].现代免疫学,2020,40(6):454-459,464.

[55]杜明民,郎晓猛,崔建从,等.参黛清肠汤介导PI3K/Akt-mTOR通路抗溃疡性结肠炎相关癌变的作用研究[J].中医药导报,2022,28(5):35-41.

[56]简小兰,曾普华,李勇敏,等.健脾消癌方对结肠癌细胞中Akt/mTOR信号通路的影响[J].中国实验方剂学杂志,2020,26(7):73-78.

[57]唐秀娟,方健松,马媛萍,等.基于PI3K-Akt-mTOR通路与EGFR及CDK1表达的健脾清热活血方含药血清对人结肠癌的影响[J].时珍国医国药,2018,29(8):1820-1824.

[58]李赞,卫真真,王子元,等.左金丸醇提物调控糖代谢改善结肠癌细胞西妥昔单抗抵抗的作用机制[J].实用肿瘤杂志,2023,38(5):439-446.

[59] SHANG L R,WANG Y C,LI J X,et al. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation[J]. J Ethnopharmacol,2023,302(Pt A):115876.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2025.06.019

中图分类号:R259

引用信息:

[1]庞龙,孙大娟,迟莉丽.中医药调控mTOR通路干预溃疡性结肠炎及其癌变研究进展[J].山东中医杂志,2025,44(06):711-720.DOI:10.16295/j.cnki.0257-358x.2025.06.019.

基金信息:

国家自然科学基金项目(编号:82205057)

发布时间:

2025-06-05

出版时间:

2025-06-05

检 索 高级检索